Long Term Follow Up Data from Phase 3 Study of CAMZYOS® (mavacamten)[...]
Edwards Lifesciences Corporation
CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent[...]
08/30/2024 | Press release | Distributed by Public on 08/30/2024 07:31
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact